Sang Joon Shin


Ontology type: schema:Person     


Person Info

NAME

Sang Joon

SURNAME

Shin

Publications in SciGraph latest 50 shown

  • 2021-05-05 ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma in NATURE
  • 2021-04-07 A phase 1 dose-escalation and dose-expansion study to assess the safety and efficacy of CKD-516, a novel vascular disrupting agent, in combination with Irinotecan in patients with previously treated metastatic colorectal cancer in INVESTIGATIONAL NEW DRUGS
  • 2020-12-03 Clinical features and KRAS mutation in colorectal cancer with bone metastasis in SCIENTIFIC REPORTS
  • 2020-08-06 Autonomy is not but competence and relatedness are associated with physical activity among colorectal cancer survivors in SUPPORTIVE CARE IN CANCER
  • 2020-04-07 Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial in TRIALS
  • 2020-04-02 Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours in BRITISH JOURNAL OF CANCER
  • 2020-03-16 Clinical Significance of Preoperative Serum Carcinoembryonic Antigen Within the Normal Range in Colorectal Cancer Patients Undergoing Curative Resection in ANNALS OF SURGICAL ONCOLOGY
  • 2019-10-14 Objectively measured physical activity during chemotherapy in colon cancer patients in SUPPORTIVE CARE IN CANCER
  • 2018-03-15 Mapping of lateral pelvic lymph node recurrences in rectal cancer: a radiation oncologist’s perspective in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2017-09-02 Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery in BMC CANCER
  • 2017-06-06 IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours in NATURE COMMUNICATIONS
  • 2017-03-28 A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors in INVESTIGATIONAL NEW DRUGS
  • 2016-10-03 Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer in ANNALS OF SURGICAL ONCOLOGY
  • 2016-07-22 High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2016-05-26 Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers in BRITISH JOURNAL OF CANCER
  • 2015-10-29 Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer in ANNALS OF SURGICAL ONCOLOGY
  • 2015-01-15 Incorporation of Radiotherapy in the Multidisciplinary Treatment of Isolated Retroperitoneal Lymph Node Recurrence from Colorectal Cancer in ANNALS OF SURGICAL ONCOLOGY
  • 2014-11-26 S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial in BMC CANCER
  • 2014-07-24 High KLF4 level in normal tissue predicts poor survival in colorectal cancer patients in WORLD JOURNAL OF SURGICAL ONCOLOGY
  • 2014-02-27 A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancer in INVESTIGATIONAL NEW DRUGS
  • 2014-01-04 Predicting the pathologic response of locally advanced rectal cancer to neoadjuvant concurrent chemoradiation using enzyme-linked immunosorbent assays (ELISAs) for biomarkers in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2013-08-27 Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2013-08-14 Prognostic Value of Mucinous Histology Depends on Microsatellite Instability Status in Patients with Stage III Colon Cancer Treated with Adjuvant FOLFOX Chemotherapy: A Retrospective Cohort Study in ANNALS OF SURGICAL ONCOLOGY
  • 2013-05-21 Prospective phase II study of neoadjuvant FOLFOX6 plus cetuximab in patients with colorectal cancer and unresectable liver-only metastasis in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2013-01-23 Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors in SUPPORTIVE CARE IN CANCER
  • 2013-01-13 Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2012-10-12 Application of the Western-based adjuvant online model to Korean colon cancer patients; a single institution experience in BMC CANCER
  • 2012-04-27 Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agent in INVESTIGATIONAL NEW DRUGS
  • 2012-03-17 Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer in EUROPEAN RADIOLOGY
  • 2012-02-16 VIPoma that arose from the rectum in a 65-year-old male patient in INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
  • 2011-11-08 Adenosine triphosphate-based chemotherapy response assay-guided chemotherapy in unresectable colorectal liver metastasis in BRITISH JOURNAL OF CANCER
  • 2011-08-24 Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases in RADIATION ONCOLOGY
  • 2011-05-24 Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2011-05-13 A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy in INVESTIGATIONAL NEW DRUGS
  • 2011-02-16 Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2010-12-29 A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy in INVESTIGATIONAL NEW DRUGS
  • 2010-08-31 The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study in RADIATION ONCOLOGY
  • 2010-05-14 Brain metastases from colorectal carcinoma: prognostic factors and outcome in JOURNAL OF NEURO-ONCOLOGY
  • 2010-03-21 Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer in INVESTIGATIONAL NEW DRUGS
  • 2009-09-16 Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2009-07-08 A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancer in INVESTIGATIONAL NEW DRUGS
  • 2009-04-21 Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2008-08-20 Postoperative adjuvant chemotherapy of gastric cancer: scrutiny into the clinical evidence based on quality assessment of medical literature of randomized controlled trials in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2007-07-24 A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status in BRITISH JOURNAL OF CANCER
  • 2007-06-19 Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2007-04-11 Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2007-03-21 The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.15444.30", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413046.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414966.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411231.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.31501.36", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.459553.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415562.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410914.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412480.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413028.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412484.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411134.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411947.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416965.9", 
            "type": "Organization"
          }
        ], 
        "familyName": "Shin", 
        "givenName": "Sang Joon", 
        "id": "sg:person.011321544242.27", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0001-5350-7241"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011321544242.27", 
          "https://orcid.org/0000-0001-5350-7241"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2021-12-01T20:43", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/person/person_786.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.011321544242.27'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.011321544242.27'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.011321544242.27'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.011321544242.27'


     

    This table displays all metadata directly associated to this object as RDF triples.

    47 TRIPLES      11 PREDICATES      26 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.011321544242.27 schema:affiliation N8cebdd7804234c44a765e53ab329382f
    2 grid-institutes:grid.31501.36
    3 grid-institutes:grid.410914.9
    4 grid-institutes:grid.411134.2
    5 grid-institutes:grid.411231.4
    6 grid-institutes:grid.411947.e
    7 grid-institutes:grid.412480.b
    8 grid-institutes:grid.412484.f
    9 grid-institutes:grid.413028.c
    10 grid-institutes:grid.413046.4
    11 grid-institutes:grid.414966.8
    12 grid-institutes:grid.415562.1
    13 grid-institutes:grid.416965.9
    14 grid-institutes:grid.459553.b
    15 schema:familyName Shin
    16 schema:givenName Sang Joon
    17 schema:identifier N0c86b268e4c54e4785a135894d0227d2
    18 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011321544242.27
    19 https://orcid.org/0000-0001-5350-7241
    20 schema:sdDatePublished 2021-12-01T20:43
    21 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    22 schema:sdPublisher N208ba27fa42f41c5a9777b5fa3af9207
    23 sgo:license sg:explorer/license/
    24 sgo:sdDataset persons
    25 rdf:type schema:Person
    26 N0c86b268e4c54e4785a135894d0227d2 schema:name orcid_id
    27 schema:value 0000-0001-5350-7241
    28 rdf:type schema:PropertyValue
    29 N208ba27fa42f41c5a9777b5fa3af9207 schema:name Springer Nature - SN SciGraph project
    30 rdf:type schema:Organization
    31 N8cebdd7804234c44a765e53ab329382f schema:affiliation grid-institutes:grid.15444.30
    32 sgo:isCurrent true
    33 rdf:type schema:OrganizationRole
    34 grid-institutes:grid.15444.30 schema:Organization
    35 grid-institutes:grid.31501.36 schema:Organization
    36 grid-institutes:grid.410914.9 schema:Organization
    37 grid-institutes:grid.411134.2 schema:Organization
    38 grid-institutes:grid.411231.4 schema:Organization
    39 grid-institutes:grid.411947.e schema:Organization
    40 grid-institutes:grid.412480.b schema:Organization
    41 grid-institutes:grid.412484.f schema:Organization
    42 grid-institutes:grid.413028.c schema:Organization
    43 grid-institutes:grid.413046.4 schema:Organization
    44 grid-institutes:grid.414966.8 schema:Organization
    45 grid-institutes:grid.415562.1 schema:Organization
    46 grid-institutes:grid.416965.9 schema:Organization
    47 grid-institutes:grid.459553.b schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...